Skip to NavigationSkip to content

Pharmafile - Business Services News

By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in their personal lives...
It’s the end of an era at NICE as its Chief Executive Sir Andrew Dillon announces that he will step down from his role at the end of March next...
Top 10 stories on Pharmafile.com this week!
The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers carrying daily...
The AveXis executives that oversaw the marketing application for Zolgensma, the $2.1 million gene therapy at the centre of the faulty data scandal...
Novartis hid faulty data from FDA over $2.1 million gene therapy Zolgensma Pfizer's sickle cell drug flops at Phase 3 trial Medicare will cover CAR-T...
MSD's Keytruda combo hits primary endpoint at Phase 3 in triple-negative breast cancer; Cigarette smoke causes superbug to become more drug resistant...
FDA approves nine generic versions of Pfizer's Lyrica, NICE to review decision-making process, and Biohaven's amyotrophic lateral sclerosis drug...
Elizabeth Warren has called on Pfizer to reveal the details of Scott Gottlieb’s appointment to the company’s Board of Directors.
This week's top 10 stories on Pharmafile.com
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches